These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1666664)

  • 1. [Clinical efficacy of combined therapy with verapamil and fast sodium channel blockers for refractory atrial fibrillation].
    Denisiuk VI; Lipnitskiĭ TN; Kotsuta GI; Stepaniuk AV
    Kardiologiia; 1991 Nov; 31(11):62-4. PubMed ID: 1666664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Feb; 70(2):37-40. PubMed ID: 1507816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of cordarone in combination with other anti-arrhythmia agents in refractory atrial fibrillation and adverse effects of the drugs].
    Denisiuk VI; Lipnitskiĭ TN; Kotsuta GI; Pilipchuk VP; Stepaniuk AV; Osiadlaia ES
    Kardiologiia; 1992 Jun; 32(6):39-42. PubMed ID: 1405291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ventricular arrhythmia resistant to sodium channel blockaders].
    Shpektor AV; Susliak NN
    Kardiologiia; 1991 Mar; 31(3):48-50. PubMed ID: 1714981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinidine plus verapamil vs. quinidine alone to prevent recurrences of atrial fibrillation.
    Veloso HH; de Paola AA
    Eur Heart J; 2005 Aug; 26(15):1568-9. PubMed ID: 15899928
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
    Daoud EG; Knight BP; Weiss R; Bahu M; Paladino W; Goyal R; Man KC; Strickberger SA; Morady F
    Circulation; 1997 Sep; 96(5):1542-50. PubMed ID: 9315545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation successfully converted. A new standard in the prevention of recurrence?].
    Fetsch T
    MMW Fortschr Med; 2001 Dec; 143(51-52):10-2. PubMed ID: 11824159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enhancement of the antifibrillatory efficacy of quinidine in atrial fibrillation by verapamil (author's transl)].
    Gülker H; Bender F; Heuer H; Thale J
    Z Kardiol; 1982 Jan; 71(1):31-4. PubMed ID: 6175119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].
    Nitschmann S; Antz M; Kuck KH
    Internist (Berl); 2005 Jul; 46(7):800-2. PubMed ID: 15947902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of supraventricular tachyarrhythmias.
    Aronow WS
    Compr Ther; 1989 Apr; 15(4):11-6. PubMed ID: 2650980
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD; Vertesi L; Dillon EC; Metcalfe C
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study.
    Mazzone C; Pandullo C; Scardi S; Salvi R; Miccio M; Cattarini G; Morgera T
    Ital Heart J; 2000 Feb; 1(2):128-36. PubMed ID: 10730613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of cardiac arrhythmias: complexity and schematization].
    Chatillon J
    Rev Med Suisse Romande; 1973 Jan; 93(1):19-36. PubMed ID: 4145983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.